Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Seeks Partners To Set Up Generic Drug Store Chain In Every District

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - India's government is seeking applications from pharmaceutical companies, non-governmental organizations and other groups as partners for a push to open a chain of low-cost generic drug stores

You may also be interested in...



India Plans To Revive Network Of Deep Discount Drug Stores

As price controls are applied on hundreds of drugs, the Indian government is revamping its own plans to provide cut-price unbranded generics. The move will make drugs available at one-fourth of the prevailing market rates.

Exclusive: India May Lean Toward Powerful Trade Body To Shore Up Low-cost Drug Program

If effective, Jan Aushadhi will play a vital role in generic drug distribution and impact industry profitability.

Eisai Expands Oncology Pipeline With SymBio Lymphoma Treatment

TOKYO - Eisai has signed a licensing agreement with Japanese start-up SymBio Pharmaceuticals to jointly develop and commercialize lymphoma treatment bendamustine (SyB L-0501) in Japan

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067574

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel